Effect of Antibiotic Prophylaxis on Infectious Complications in Patients with Asymptomatic Bacteriuria Undergoing Urologic Surgery

J. Ramos-Castaneda, A. Ruano-Raviña, Javier Osorio-Manrique, Jackeline Barreto-Mora, A. Segura-Cardona, Elkin V. Lemos-Luengas
{"title":"Effect of Antibiotic Prophylaxis on Infectious Complications in Patients with Asymptomatic Bacteriuria Undergoing Urologic Surgery","authors":"J. Ramos-Castaneda, A. Ruano-Raviña, Javier Osorio-Manrique, Jackeline Barreto-Mora, A. Segura-Cardona, Elkin V. Lemos-Luengas","doi":"10.1055/s-0041-1730320","DOIUrl":null,"url":null,"abstract":"Abstract Objectives To identify the effect of duration of surgical antibiotic prophylaxis (SAP) and other variables on infectious postsurgical complications in patients with asymptomatic bacteriuria (ASB) undergoing urological surgery. Methods We conducted an observational study of a cohort of patients with ASB scheduled for urologic surgery at three health service providers in Colombia. The study population comprised all patients with planned urologic surgery who had ASB prior to surgery from April 2018 to January 2019. The intervention evaluated was the duration of preoperative SAP, and the outcome variable was the development of any postoperative infectious complications for up to 30 days after the procedure. Results The present study included 184 patients with ASB scheduled for urologic surgery. The median duration of preoperative SAP (p = 0.49) or of 1 dose SAP (risk ratio [RR] = 1.24; 95% confidence interval [CI]: 0.45–3.39) were not statistically different in patients with postsurgical infectious complications. Infectious complications were more frequent among patients with benign prostatic hyperplasia (RR = 6.57; 95%CI: 1.98–21.76) and hospitalization in the preceding 3 months (RR = 8.32; 95%CI: 2.69–25.71). Conclusion One dose of antimicrobial therapy is sufficient to avoid infectious complications in patients with ASB. There were other factors associated with postsurgical infectious complications, such as benign prostatic hyperplasia and hospitalization in the preceding 3 months.","PeriodicalId":38070,"journal":{"name":"Urologia Colombiana","volume":"30 1","pages":"e157 - e164"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologia Colombiana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1730320","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Objectives To identify the effect of duration of surgical antibiotic prophylaxis (SAP) and other variables on infectious postsurgical complications in patients with asymptomatic bacteriuria (ASB) undergoing urological surgery. Methods We conducted an observational study of a cohort of patients with ASB scheduled for urologic surgery at three health service providers in Colombia. The study population comprised all patients with planned urologic surgery who had ASB prior to surgery from April 2018 to January 2019. The intervention evaluated was the duration of preoperative SAP, and the outcome variable was the development of any postoperative infectious complications for up to 30 days after the procedure. Results The present study included 184 patients with ASB scheduled for urologic surgery. The median duration of preoperative SAP (p = 0.49) or of 1 dose SAP (risk ratio [RR] = 1.24; 95% confidence interval [CI]: 0.45–3.39) were not statistically different in patients with postsurgical infectious complications. Infectious complications were more frequent among patients with benign prostatic hyperplasia (RR = 6.57; 95%CI: 1.98–21.76) and hospitalization in the preceding 3 months (RR = 8.32; 95%CI: 2.69–25.71). Conclusion One dose of antimicrobial therapy is sufficient to avoid infectious complications in patients with ASB. There were other factors associated with postsurgical infectious complications, such as benign prostatic hyperplasia and hospitalization in the preceding 3 months.
抗生素预防对泌尿外科无症状菌尿患者感染并发症的影响
抽象目标 确定外科抗生素预防(SAP)的持续时间和其他变量对接受泌尿外科手术的无症状菌尿(ASB)患者术后感染性并发症的影响。方法 我们对哥伦比亚三家医疗服务机构计划进行泌尿外科手术的ASB患者队列进行了一项观察性研究。研究人群包括2018年4月至2019年1月手术前患有ASB的所有计划进行泌尿外科手术的患者。评估的干预措施是术前SAP的持续时间,结果变量是术后30天内任何术后感染性并发症的发展。后果 本研究纳入了184名计划进行泌尿外科手术的ASB患者。术前SAP的中位持续时间(p = 0.49)或1剂SAP(风险比[RR] = 1.24;95%置信区间[CI]:0.45-3.39)在术后感染并发症患者中没有统计学差异。感染性并发症在良性前列腺增生患者中更为常见(RR = 6.57;95%置信区间:1.98–21.76)和前3个月的住院情况(RR = 8.32;95%可信区间:2.69–25.71)。结论 一剂抗微生物治疗足以避免ASB患者的感染性并发症。还有其他与术后感染并发症相关的因素,如良性前列腺增生和前3个月的住院治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urologia Colombiana
Urologia Colombiana Medicine-Urology
CiteScore
0.30
自引率
0.00%
发文量
26
期刊介绍: Urología Colombiana is the serial scientific publication of the Colombian Society of Urology at intervals of three issues per year, in which the results of original research, review articles and other research designs that contribute to increase knowledge in medicine and particularly in the specialty of urology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信